In 2021 - 2022, a stronger dose, weekly injectable formulation of Semaglutide (brand name Wegovy) was approved by the US FDA as a medication for weight loss in patients with at least one weight related medical issue
If you haven't yet explored genetic testing, adding the Precision Peptide Genetic Test ($99) after your first treatment month provides actionable insights for supplement selection and tirzepatide personalization
Dosing accuracy with compounded injectables requires careful adherence to clinician and pharmacy instructions
The Phase 2 trial of eloralintide was reported in The Lancet
We selected SURMOUNT-5 because its transparent, peer-reviewed, methodologically rigorous, and mirrors real-world GLP-1 use: weekly injections, common health challenges, modern obesity doses, identical background conditions